Hints and tips:
Related Special Reports
...Rahul Titus, global head of influence at Ogilvy PR, said health influence was the “new frontier” in marketing....
...The controversy over Soriot’s pay also comes as the UK seeks to encourage more companies to remain listed in London amid a global battle for talent....
...BCG is working with global tech giants and AI companies — from Microsoft and Google to OpenAI and Anthropic — to integrate their technology into company operations and processes....
...The Development Bank of Japan is investing in 4Bio, which funds companies in the UK and Europe, alongside the Japanese pharma group Kyowa Kirin, and US healthcare provider, Children’s Minnesota. 4Bio aims...
...Pharma groups and biotechs can be locked into contracts with WuXi for up to five years into the future, said Crowley....
...However, a Japanese executive from Astellas Pharma was arrested last year in China on suspicion of espionage....
...“This industry is a global industry and a lot of the talent is based in the US.”...
...IDA’s Lohan warned of erecting new “barriers within the research and development cycle of new treatments” and possibly delaying market access....
...WuXi AppTec is a major supplier of essential ingredients to many of the largest global pharmaceutical companies and conducts drug development for them....
...“[This means] the return on investment for antibacterials is much lower than other types of drug development.”...
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...If Pfizer had followed this route to market for anti-obesity drugs, rather than its own development efforts, its post-Covid plans would be more secure....
...Astellas Pharma bought eye-treatment specialist Iveric Bio in a $5.9bn deal in May. Mizuho splashed out $550mn for US boutique investment bank Greenhill & Co....
...Its 2030 obesity and diabetes sales in China are expected to reach $4.8bn, or 7 per cent of the global total, according to Visible Alpha. But there is an opportunity for local pharma groups....
...Astellas Pharma has agreed to buy US biotech group Iveric Bio for roughly $5.9bn, marking the Japanese drugmaker’s largest-ever acquisition and giving it access to the rapidly expanding market for age-related...
...Japan has said 17 of its citizens have been detained since China passed a counter-espionage law in 2014, of whom five remain in detention, including an executive of Astellas Pharma who was taken into custody...
...Maybe in March it was, but in April it’s starting to look functional again,” said Alex Brill, chief executive of Matrix Global Advisors, a healthcare consultancy....
..., a senior research fellow at the Canon Institute for Global Studies think-tank....
...This is Europe’s largest medical research centre, home to AstraZeneca’s global headquarters and expected to accommodate 27,000 jobs by 2031. But the city’s housing supply has failed to keep up....
...Investment in AI-boosted vaccine development has grown since the Covid-19 pandemic, as has interest in the idea of adaptable jabs that can be quickly updated to deal with new virus mutations....
...The first three sources are not the exclusive realm of knowledge industries such as tech or pharma....
...“The big keep getting bigger,” said Peter Oppenheimer, Goldman’s chief global equity strategist and head of macro....
...The global contract development and manufacturing market, which supports pharma companies in making products and running clinical trials, is projected to grow from $72bn to $90bn over the next two years,...
...He was previously chief of the Roche diagnostics business, and is now focusing on improving the future of the pharmaceutical division with internal development and deals, after disappointments including...
...The job cuts come as the slowdown in sales of EVs makes waves across the global car industry, with companies across the supply chain from South Korea to Germany slashing jobs and costs....
International Edition